Abstract: Pipelined digital processing circuitry for use with a particle size measurement system, such as that employed in automated hematology systems, measures the ‘center’ amplitude of a pulse produced by a particle or cell passing through a flow cell measurement aperture, such as the detection aperture of a Coulter Principle-based electronic particle analysis system. The circuitry of the invention processes successive pulse samples by means of a half-peak/half-width methodology that analyzes each pulse as its continuously sampled and temporarily stored in memory. Concurrent analysis of the data in memory during storage locates the pulse width at a prescribed percentage (e.g., 50%) of the peak amplitude of the pulse. This pulse width data is then processed to determine the pulse amplitude at the midpoint of the width of the pulse between its mid-peak values on rising edge and fall edge portions of the pulse.

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: A method and apparatus for updating a design knowledge base, comprising supplying a design knowledge base (14) in a selected domain, the design knowledge base configured to obtain user input (24) of a selected design and to output a design directive. A response is received from the design knowledge base to the user input of a selected design wherein the response comprises a set of design review inquiries to direct the user to incorporate the design directive.

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: An automotive trim component (10) is provided which enables an aesthetic feature (26) of a trim component (10) to be observed by a vehicle occupant when the aesthetic feature (26) is viewed by the vehicle occupant through a portion of the trim component (32).

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.

Abstract: An itch reducing device and method for reducing the itch of a mosquito bite. The itch reducing device and method includes a pad comprising an absorbent material. An itch reducing ointment generally saturates the pad. A package has an upper layer and a lower layer joined at perimeter edges of the upper and lower layers. The pad is positioned in the package for storage until needed.

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: A disengageable electrical capacitive coupling system with enhanced conductivity of the coupling is provided. The coupling is designed for transmitting high frequency AC electrical current and includes dual connectors on the vehicle side mating with dual couplers on the charger side. The system includes a selection of applicators for applying liquid cleaner materials to the plates of the dual connectors/couplers to loosen and remove substantially all foreign particles, as well as air pockets. The applicators include porous rollers, a combination spray nozzle and squeegee, a direct applicator through the foam forming the coupler plates and a scraper to provide additional beneficial treatment to the plate surface. The cleaner materials can be water or a conductive liquid solution, including an additive of a strong electrolyte, to further enhance the coupling function.

Abstract: The present invention provides novel compounds that function as immunological adjuvants when co-administered with antigens, including, antigens used as vaccines for any disease or condition amenable to vaccination. The invention also provides adjuvant formulations comprising the novel compounds of the invention and methods for immunizing humans and non-human animals.

Abstract: The present invention is directed to novel compounds that function as immunological adjuvants when co-administered with antigens such as vaccines for bacterial and viral diseases, to novel adjuvant formulations which include at least one of the adjuvant compounds of the invention, to novel immunostimulatory compositions which comprise an antigen and at least one of the adjuvant compounds of the invention, and to methods for the immunization of an animal by co-administration of a compound of the invention with an antigen against which the animal is to be immunized.

Abstract: A disengageable electrical capacitive coupling for transmitting high frequency AC electrical current is provided. In an electric vehicle charging system, dual first connectors form the vehicle inlet, and mating dual second connectors form the coupler. A dielectric material, such as barium titanium oxide, is positioned between the connectors to form capacitors. A holder secures the connectors together with the dielectric material in between. The interface formed is sufficient for establishing a highly efficient, compact electrostatic field for transmitting the current. Provision is made in the holder for easily disengaging the connectors once the charging cycle is complete. When utilized as a charging system, the capacitive charge coupling is connected between a high frequency drive unit on the charger side and a DC power conversion unit on the energy storage side, such as in an electric vehicle.

Abstract: A method and apparatus is provided to charge a battery including a DC charge current supply having a variable output. The charging current is varied in accordance with several sensed parameters in the circuit so that battery voltage is accurately controlled. Initially, constant charging current is applied, and upon detecting that battery voltage increases to the gassing voltage, an incremental step reduction in charging current is triggered. The step reduction causes a decrease in battery voltage, dropping it below the gassing voltage. The step reduced charging current is then applied to increase battery voltage back up to the gassing voltage, thereby triggering another step reduction in charging current. This process is repeated multiple times providing a stepped current profile, i.e., each battery voltage increase to the gassing voltage triggering a step reduction in charging current, and in turn a corresponding voltage reduction.

Abstract: A method and apparatus is provided to charge a battery including a DC charge current supply having a variable output. The charging current is varied in accordance with several sensed parameters in the circuit so that battery voltage is accurately controlled. Initially, constant charging current is applied, and upon detecting that battery voltage increases to the gassing voltage, an incremental step reduction in charging current is triggered. The step reduction causes a decrease in battery voltage, dropping it below the gassing voltage. The step reduced charging current is then applied to increase battery voltage back up to the gassing voltage, thereby triggering another step reduction in charging current. This process is repeated multiple times providing a stepped current profile, i.e., each battery voltage increase to the gassing voltage triggering a step reduction in charging current, and in turn a corresponding voltage reduction.